Skip to content
777 Sourcing.

Capability

computer modeling/artificial intelligence in drug discovery

Suppliers
1
States & provinces
1
Countries
1

1 computer modeling/artificial intelligence in drug discovery supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

FLAG THERAPEUTICS, INC

RALEIGH, NC

FLAG Therapeutics, Inc. is a near-term clinical stage company headquartered in Raleigh, North Carolina, focused on developing new small molecule therapeutics for difficult-to-treat cancers. Its lead candidate, FLAG-003, targets diffuse intrinsic pontine glioma (DIPG) and glioblastoma multiforme (GBM) and is projected to enter Phase 1/2 clinical development in early 2026 in children with DIPG. The company leverages three proprietary drug discovery platforms and holds an exclusive worldwide licensing agreement with Duquesne University.

drug developmentdrug discoverysmall-molecule therapeutics

Compiled from public sources

Related capabilities

Other processes offered by the shops that list computer modeling/artificial intelligence in drug discovery.

Browse all capabilities